These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20826029)

  • 1. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
    Wu SX; Cui TT; Zhao C; Pan JJ; Xu BY; Tian Y; Cui NJ
    Radiother Oncol; 2010 Oct; 97(1):113-8. PubMed ID: 20826029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
    Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
    Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
    Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT;
    J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'sullivan B; Xu SL; Pang ES; Sze WM; Leung TW; Kwan WH; Chan PT; Liu XF; Tan EH; Sham JS; Siu L; Lau WH
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):142-51. PubMed ID: 16904519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
    Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
    Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Celik I; Kars A; Ozyar E; Tekuzman G; Atahan L; Firat D
    J Clin Oncol; 1996 Mar; 14(3):1043-4. PubMed ID: 8622011
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
    Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concurrent chemoradiotherapy with sodium glycididazole and cisplatin for local advanced nasopharyngeal carcinoma].
    He ZY; Li FY; Tong Q; Liao ZW; Guan XX; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2038-40. PubMed ID: 19033122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
    Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
    Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial.
    Chitapanarux I; Lorvidhaya V; Kamnerdsupaphon P; Sumitsawan Y; Tharavichitkul E; Sukthomya V; Ford J
    Eur J Cancer; 2007 Jun; 43(9):1399-406. PubMed ID: 17467265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The long-term therapeutic results of chemotherapy combined with radiotherapy in advanced nasopharyngeal carcinoma].
    Gu Z; Wei Q; Huang K
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):392-4. PubMed ID: 10920926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.
    Poon D; Yap SP; Wong ZW; Cheung YB; Leong SS; Wee J; Tan T; Fong KW; Chua ET; Tan EH
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1312-8. PubMed ID: 15275714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
    de Crevoisier R; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.